SGH
EW icon

Schonfeld Group Holdings’s Edwards Lifesciences EW Stock Holding History

Schonfeld Group Holdings’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-36,432
Closed -$450K – 133
2014
Q1 		$450K Buy
+36,432
New +$420K 0.11% 272

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Schonfeld Group Holdings's EW Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 36,432 shares — an estimated $450K sold.

Schonfeld Group Holdings first reported a position in EW in Q1 2014 and held it in 1 quarter. The position peaked at $450K in Q1 2014. 428 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 36,432 Edwards Lifesciences shares in Q2 2014, an estimated $450K.
  • Schonfeld Group Holdings first reported a position in Edwards Lifesciences in Q1 2014 and held it in 1 quarter.
  • Schonfeld Group Holdings's Edwards Lifesciences position peaked at $450K in Q1 2014.
  • 428 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.